Renal Insufficiency, Chronic
-
Subject Areas on Research
-
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
-
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
-
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
-
A 4-year survey of the spectrum of renal disease at a National Referral Hospital Outpatient Clinic in Uganda.
-
A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.
-
A National Registry for People With All Stages of Kidney Disease: The National Kidney Foundation (NKF) Patient Network.
-
A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population.
-
A Novel Approach to Developing a Discordance Index for Older Adults With Chronic Kidney Disease.
-
A Quality Improvement Intervention to Improve the Efficiency of Arteriovenous Access Placement for Pre-Dialysis Inpatients.
-
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial.
-
A massive pelvic mucocele presenting as a cystic sacral mass.
-
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?
-
A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia.
-
A review of molecular mechanisms linked to potential renal injury agents in tropical rural farming communities.
-
A rose by any other name: is stage 3a chronic kidney disease really a disease?
-
A study assessing the association of glycated hemoglobin A1C (HbA1C) associated variants with HbA1C, chronic kidney disease and diabetic retinopathy in populations of Asian ancestry.
-
A varying patient safety profile between black and nonblack adults with decreased estimated GFR.
-
APOL1 risk alleles among individuals with CKD in Northern Tanzania: A pilot study.
-
APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
-
Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
-
Access to CKD Care in Rural Communities of India: a qualitative study exploring the barriers and potential facilitators.
-
Acid Load and Phosphorus Homeostasis in CKD.
-
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.
-
Active vitamin D and survival.
-
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression.
-
Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome.
-
Acute kidney injury and chronic kidney disease after cardiac surgery.
-
Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response.
-
Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: A report from the National Cardiovascular Data Registry CathPCI Registry.
-
Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
-
Albuminuria and Heart Failure: JACC State-of-the-Art Review.
-
Ambulatory blood pressure in chronic kidney disease: do ethnic disparities exist?
-
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus.
-
An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States.
-
Angiotensin receptors in the kidney and vasculature in hypertension and kidney disease.
-
Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
-
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.
-
Apparent treatment-resistant hypertension and chronic kidney disease: another cardiovascular-renal syndrome?
-
Applicability of Novel Urinary Biomarkers for the Assessment of Renal Injury in Selected Occupational Groups in Sri Lanka: A Comparative Study with Conventional Markers.
-
Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease?
-
Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients.
-
Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program.
-
Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
-
Association between serum gamma-glutamyltransferase and chronic kidney disease among US adults.
-
Association of Arterial Stiffness With Kidney Function Among Adults Without Chronic Kidney Disease.
-
Association of Chronic Renal Insufficiency With In-Hospital Outcomes in Primary Atrial Fibrillation Hospitalizations.
-
Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
-
Association of Fitness With Racial Differences in Chronic Kidney Disease.
-
Association of Kidney Function With 30-Day and 1-Year Poststroke Mortality and Hospital Readmission.
-
Association of Multimorbidity with Mortality and Healthcare Utilization in Chronic Kidney Disease.
-
Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
-
Association of Reduced eGFR and Albuminuria with Serious Fall Injuries among Older Adults.
-
Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality.
-
Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function.
-
Association of acute kidney injury and chronic kidney disease with processes of care and long-term outcomes in patients with acute myocardial infarction.
-
Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease.
-
Association of functional and structural social support with chronic kidney disease among African Americans: the Jackson Heart Study.
-
Association of proton-pump inhibitor use with adverse health outcomes: A systematic umbrella review of meta-analyses of cohort studies and randomised controlled trials.
-
Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
-
Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.
-
Associations of toothbrushing behaviour with risks of vascular and nonvascular diseases in Chinese adults.
-
Atrial Fibrillation and Risk of ESRD in Adults with CKD.
-
Awareness and Discussions About Chronic Kidney Disease Among African-Americans with Chronic Kidney Disease and Hypertension: a Mixed Methods Study.
-
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
-
Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function.
-
Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis.
-
Blood volume and chronic kidney disease in heart failure - Can volume expansion help balance the Cardio-Renal Axis for better clinical outcomes?
-
Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease.
-
Both chronic kidney disease and nocturnal blood pressure associate with strokes in the elderly.
-
Branch chain amino acids: biomarkers of health and disease.
-
CKD as a Model for Improving Chronic Disease Care through Electronic Health Records.
-
CKD of Uncertain Etiology: A Systematic Review.
-
COVID-19 and the Kidney Community: Coalescing in Crisis.
-
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015.
-
Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.
-
Cardiorenal interactions: insights from the ESCAPE trial.
-
Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial.
-
Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR-TIMI 53 cardiovascular outcomes trials.
-
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
-
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.
-
Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.
-
Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care.
-
Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial.
-
Challenges perceived by primary care providers to educating patients about chronic kidney disease.
-
Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial.
-
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States.
-
Characteristics and in-hospital outcomes of patients presenting with non-ST-segment elevation myocardial infarction found to have significant coronary artery disease on coronary angiography and managed medically: stratification according to renal function.
-
Characterizing chronological accumulation of comorbidities in healthy veterans: a computational approach.
-
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
-
Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.
-
Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.
-
Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke.
-
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
-
Chronic kidney disease and recurrent falls in nursing home residents: a retrospective cohort study.
-
Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
-
Chronic kidney disease and stroke.
-
Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
-
Chronic kidney disease biomarkers and mortality among older adults: A comparison study of survey samples in China and the United States.
-
Chronic kidney disease in low- and middle-income countries.
-
Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population.
-
Chronic kidney disease.
-
Chronic pain and analgesic use in CKD: implications for patient safety.
-
Clin-Star corner: What is new at the interface of geriatrics and nephrology?
-
Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.
-
Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration.
-
Clinical Update on Nursing Home Medicine: 2016.
-
Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function.
-
Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease.
-
Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort Study.
-
Clinical outcomes and treatment patterns among Medicare patients with nonvalvular atrial fibrillation (NVAF) and chronic kidney disease.
-
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.
-
Common variants in Mendelian kidney disease genes and their association with renal function.
-
Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study.
-
Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study.
-
Comorbidities in Heart Failure: Are There Gender Differences?
-
Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease.
-
Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.
-
Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.
-
Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.
-
Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.
-
Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease.
-
Connecting cytokines and cellular signals in the nephron during CKD and hypertension.
-
Consideration of ICD-9 code-derived disease-specific safety indicators in CKD.
-
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.
-
Contemporary mineral metabolism for clinicians and scientists: introduction.
-
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference.
-
Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease.
-
Coronary artery disease in chronic kidney disease: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
-
Correction of anemia with epoetin alfa in chronic kidney disease.
-
Correlates of left ventricular mass in chronic hemodialysis recipients.
-
Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.
-
Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study.
-
Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.
-
Cystatin C and Creatinine-Based Equations Compared with Measured Glomerular Filtration Rate in Pediatrics: Future Challenges.
-
DASH Diet and Blood Pressure Among Black Americans With and Without CKD: The Jackson Heart Study.
-
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
-
Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol.
-
Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply.
-
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
-
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
-
Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry.
-
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
-
Defining kidney outcomes in children with acute lymphoblastic leukemia in the modern era.
-
Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations.
-
Depression in patients with chronic kidney disease on dialysis in Saudi Arabia.
-
Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension.
-
Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial.
-
Development and validation of a cross-cultural knowledge, attitudes, and practices survey instrument for chronic kidney disease in a Swahili-speaking population.
-
Development of Risk Prediction Equations for Incident Chronic Kidney Disease.
-
Device therapy in heart failure patients with chronic kidney disease.
-
Diabetes mellitus and chronic kidney disease in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study.
-
Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions.
-
Diabetic kidney disease: a report from an ADA Consensus Conference.
-
Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD.
-
Dietary acid load: a novel nutritional target in chronic kidney disease?
-
Disordered FGF23 and mineral metabolism in children with CKD.
-
Disparities in Chronic Kidney Disease Progression by Medicare Advantage Enrollees.
-
Disparities in Discussions about Kidney Replacement Therapy in CKD Care.
-
Disparities in the burden, outcomes, and care of chronic kidney disease.
-
Distribution of survival times in a real-world cohort of older adults with chronic kidney disease: the median may not be the message.
-
Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.
-
Does the presence of coronary artery disease impact perioperative outcomes following partial hepatectomy?
-
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II).
-
Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care.
-
Effect of Bicarbonate on Net Acid Excretion, Blood Pressure, and Metabolism in Patients With and Without CKD: The Acid Base Compensation in CKD Study.
-
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.
-
Effect of Genetic African Ancestry on eGFR and Kidney Disease.
-
Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
-
Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS.
-
Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.
-
Effect of renal function on antihypertensive drug safety and efficacy in children.
-
Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials.
-
Effectiveness and acceptability of a multidisciplinary approach in improving the care of patients with advanced chronic kidney disease: a pilot study.
-
Effectiveness of educational and social worker interventions to activate patients' discussion and pursuit of preemptive living donor kidney transplantation: a randomized controlled trial.
-
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.
-
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.
-
Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.
-
Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.
-
Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial.
-
Effects of phosphate binders in moderate CKD.
-
Effects of serum creatinine calibration on estimated renal function in african americans: the Jackson heart study.
-
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials.
-
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.
-
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.
-
Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults.
-
Empagliflozin in Patients with Chronic Kidney Disease.
-
Epidemiology of chronic kidney disease among older adults: a focus on the oldest old.
-
Establishing core outcome domains in pediatric kidney disease: report of the Standardized Outcomes in Nephrology-Children and Adolescents (SONG-KIDS) consensus workshops.
-
Estimated Glomerular Filtration Rate Variability in Patients With Heart Failure and Chronic Kidney Disease.
-
Estimating kidney function in HIV-infected adults in Kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearance.
-
Estimation of Black-White Disparities in CKD Outcomes: Comparison Using the 2021 Versus the 2009 CKD-EPI Creatinine Equations.
-
Estimation of GFR in South Asians: a study from the general population in Pakistan.
-
Ethnic differences in the association between blood pressure components and chronic kidney disease in middle aged and older Asian adults.
-
Ethnic variation in the impact of metabolic syndrome components and chronic kidney disease.
-
Evaluation of renal function before and after percutaneous mitral valve repair.
-
Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
-
Exome-Based Rare-Variant Analyses in CKD.
-
Exosomal CCL2 from Tubular Epithelial Cells Is Critical for Albumin-Induced Tubulointerstitial Inflammation.
-
FDA approval of dapagliflozin for chronic kidney disease: a remarkable achievement?
-
FGF23 and Left Ventricular Hypertrophy in Children with CKD.
-
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis.
-
FGF23 modifies the relationship between vitamin D and cardiac remodeling.
-
FGFR4 does not contribute to progression of chronic kidney disease.
-
FIH-1-modulated HIF-1α C-TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling.
-
Factors Associated with Chronic Kidney Disease and Their Clinical Utility in Primary Care Clinics in a Multi-Ethnic Southeast Asian Population.
-
Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes.
-
Feasibility and Functional Testing for Frailty in Chronic Kidney Disease.
-
Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study.
-
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
-
Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.
-
Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
-
Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study.
-
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
-
Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function.
-
Fibroblast growth factor 23 and Inflammation in CKD.
-
Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
-
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
-
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
-
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.
-
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
-
Fibroblast growth factor-23 and cardiovascular events in CKD.
-
Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes.
-
Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial.
-
Folic acid supplementation and chronic kidney disease progression.
-
Food Access, Chronic Kidney Disease, and Hypertension in the U.S.
-
Frequency of hypoglycemia and its significance in chronic kidney disease.
-
GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease.
-
Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study.
-
Genetic Abrogation of Adenosine A3 Receptor Prevents Uninephrectomy and High Salt-Induced Hypertension.
-
Genetic African Ancestry and Markers of Mineral Metabolism in CKD.
-
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.
-
Genetic background influences cardiac phenotype in murine chronic kidney disease.
-
Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
-
Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study.
-
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015.
-
Goal-Striving Stress Is Associated with Chronic Kidney Disease Among Participants in the Jackson Heart Study.
-
Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CON.
-
Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial.
-
HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.
-
HIV at 40: kidney disease in HIV treatment, prevention, and cure.
-
Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.
-
Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfection.
-
Health information technology (IT) to improve the care of patients with chronic kidney disease (CKD).
-
Healthcare professionals' perceptions of the role of a multidisciplinary approach in improving the care of patients with advanced chronic kidney disease.
-
Healthcare professionals' perspectives on facilitators of and barriers to CKD management in primary care: a qualitative study in Singapore clinics.
-
Heavy metal nephropathy: considerations for exposure analysis.
-
Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.
-
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
-
Hepcidin and disordered mineral metabolism in chronic kidney disease.
-
High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study.
-
High-dose IV iron for anemia correction in chronic kidney disease.
-
High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target?
-
Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes.
-
Hospital discharge communications during care transitions for patients with acute kidney injury: a cross-sectional study.
-
Hospitalizations among adults with chronic kidney disease in the United States: A cohort study.
-
Hospitalized hemorrhagic stroke patients with renal insufficiency: clinical characteristics, care patterns, and outcomes.
-
Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy.
-
Hypertensive Diseases in Pregnancy and Kidney Function Later in Life: The Genetic Epidemiology Network of Arteriopathy (GENOA) Study.
-
Hypoxia signaling in renal pericytes-is it safe to activate?
-
ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials.
-
ISCHEMIA-EXTEND studies: Rationale and design.
-
Ideal high sensitivity troponin baseline cutoff for patients with renal dysfunction.
-
Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease.
-
Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
-
Impact of Continuous Flow Left Ventricular Assist Device Therapy on Chronic Kidney Disease: A Longitudinal Multicenter Study.
-
Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients.
-
Impact of automated reporting of estimated glomerular filtration rate in the veterans health administration.
-
Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial.
-
Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial.
-
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials.
-
Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR.
-
Impact of renal dysfunction on acute coronary syndrome evaluation in observation unit patients.
-
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies.
-
Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.
-
Implementation of automated reporting of estimated glomerular filtration rate among Veterans Affairs laboratories: a retrospective study.
-
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.
-
Importance of Metabolic Acidosis as a Health Risk in Chronic Kidney Disease.
-
Improving Primary Care for Patients With CKD in the Digital Era.
-
Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C3) study protocol.
-
Improving the prediction of hypertensive target organ damage using novel markers: lessons from retinal vascular imaging research.
-
In experimental chronic kidney disease or cancer, parathyroid hormone is a novel mediator of cachexia.
-
In reply to 'validating GFR estimating samples with clinical outcomes'.
-
In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?
-
Incidence and Predictors of Adverse Events Among Initially Stable ST-Elevation Myocardial Infarction Patients Following Primary Percutaneous Coronary Intervention.
-
Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes.
-
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).
-
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP.
-
Incorporating Geriatric Assessment into a Nephrology Clinic: Preliminary Data from Two Models of Care.
-
Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease - A Population-Based Study.
-
Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study.
-
Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients.
-
Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
-
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
-
Inflammatory Markers and Incidence of Hospitalization With Infection in Chronic Kidney Disease.
-
Influence of chronic kidney disease on warfarin therapy for atrial fibrillation.
-
Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease.
-
Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease.
-
Intensive glycemic control and the risk of end-stage renal disease: an ADVANCE in the management of diabetes?
-
Interleukin-9 mediates chronic kidney disease-dependent vein graft disease: a role for mast cells.
-
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.
-
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease.
-
Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment.
-
Is chronic kidney disease associated with diabetic retinopathy in Asian adults?
-
Is microvascular dysfunction a systemic disorder with common biomarkers found in the heart, brain, and kidneys? - A scoping review.
-
Is renal function associated with early age-related macular degeneration?
-
Is there something better than the best marker of kidney function?
-
Kidney Function and Outcomes in Patients Hospitalized With Heart Failure.
-
Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKD.
-
Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database.
-
Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study.
-
Kidney developmental effects of metal-herbicide mixtures: Implications for chronic kidney disease of unknown etiology.
-
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
-
Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
-
Knowledge, Attitudes, and Practices Associated with Chronic Kidney Disease in Northern Tanzania: A Community-Based Study.
-
Lab-based and diagnosis-based chronic kidney disease recognition and staging concordance.
-
Limited health literacy is associated with low glomerular filtration in the Chronic Renal Insufficiency Cohort (CRIC) study.
-
Long-Term Blood Pressure Variability, New-Onset Diabetes Mellitus, and New-Onset Chronic Kidney Disease in the Japanese General Population.
-
Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria.
-
Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
-
Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.
-
Longitudinal study of glomerular hyperfiltration in adults with sickle cell anemia: a multicenter pooled analysis.
-
Low use of routine medical care among African Americans with high CKD risk: the Jackson Heart Study.
-
MYH9 E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration.
-
Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry.
-
Management of Coronary Disease in Patients with Advanced Kidney Disease.
-
Management of acute coronary syndromes in patients with renal dysfunction.
-
Management of anemia in children receiving chronic peritoneal dialysis.
-
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
-
Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
-
Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments.
-
Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD.
-
Markers of Renal Function in Older Adults Completing a Higher Protein Obesity Intervention and One Year Later: Findings from the MEASUR-UP Trial.
-
Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease.
-
Meta-analyses identify DNA methylation associated with kidney function and damage.
-
Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations.
-
Metabolic Changes with Base-Loading in CKD.
-
Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Mineral (Mal)Adaptation to Kidney Disease--Young Investigator Award Address: American Society of Nephrology Kidney Week 2014.
-
Mineral metabolites and CKD progression in African Americans.
-
Minithoracotomy versus sternotomy for mitral surgery in patients with chronic renal impairment: a propensity-matched study.
-
Missing Care: the Initial Impact of the COVID-19 Pandemic on CKD Care Delivery.
-
Mobile Health (mHealth) Technology: Assessment of Availability, Acceptability, and Use in CKD.
-
Modifiers of Plasma 25-Hydroxyvitamin D and Chronic Kidney Disease Outcomes in Black Americans: The Jackson Heart Study.
-
Mortality after myocardial infarction: the role of renal function and systolic and diastolic functions of the left ventricle.
-
Multiple, objectively measured sleep dimensions including hypoxic burden and chronic kidney disease: findings from the Multi-Ethnic Study of Atherosclerosis.
-
Nationwide Trends and Variations in Urological Surgical Interventions and Renal Outcome in Patients with Spina Bifida.
-
Neighborhood clustering of non-communicable diseases: results from a community-based study in Northern Tanzania.
-
Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study.
-
Nephrotoxic contaminants in drinking water and urine, and chronic kidney disease in rural Sri Lanka.
-
New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management.
-
New-onset hypertension and risk for chronic kidney disease in the Japanese general population.
-
Nondepressive Psychosocial Factors and CKD Outcomes in Black Americans.
-
Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS Study.
-
Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease.
-
Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.
-
Novel Models for Health Care Delivery for CKD for Disadvantaged Populations.
-
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.
-
Older Patients' Perspectives on Managing Complexity in CKD Self-Management.
-
Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease.
-
Optimism is associated with chronic kidney disease and rapid kidney function decline among African Americans in the Jackson Heart Study.
-
Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction.
-
Outcomes of Ureteroscopic Stone Treatment in Patients With Spinal Cord Injury.
-
Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease.
-
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study.
-
Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19.
-
Patient Education and Support During CKD Transitions: When the Possible Becomes Probable.
-
Patient characteristics, care patterns, and outcomes of atrial fibrillation associated hospitalizations in patients with chronic kidney disease and end-stage renal disease.
-
Patient discourse on chronic kidney disease monitoring: a qualitative study at a Veterans Affairs Renal Clinic.
-
Patient perspectives and involvement in precision medicine research.
-
Patient-Reported Safety Events in Chronic Kidney Disease Recorded With an Interactive Voice-Inquiry Dial-Response System: Monthly Report Analysis.
-
Patient-reported and actionable safety events in CKD.
-
Patients' and Nephrologists' Evaluation of Patient-Facing Smartphone Apps for CKD.
-
Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
-
Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months.
-
Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD.
-
Patterns of care quality and prognosis among hospitalized ischemic stroke patients with chronic kidney disease.
-
Perceived Susceptibility to Chronic Kidney Disease and Hypertension Self-Management among Black and White Live Kidney Donors.
-
Perceived barriers and facilitators of using dietary modification for CKD prevention among African Americans of low socioeconomic status: a qualitative study.
-
Perceived barriers and facilitators to chronic kidney disease care among patients in Singapore: a qualitative study.
-
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.
-
Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.
-
Performance of depression rating scales in patients with chronic kidney disease: an item response theory-based analysis.
-
Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study.
-
Pharmacodynamic effects of cilostazol versus clopidogrel in stented patients under proton pump inhibitor co-administration: the ACCEL-PARAZOL study.
-
Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.
-
Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association.
-
Phosphate REINs in the renoprotective benefit of ACE inhibition.
-
Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation.
-
Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
-
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS).
-
Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure.
-
Plasticity of renal erythropoietin-producing cells governs fibrosis.
-
Postoperative Acute Kidney Injury Is Associated With Progression of Chronic Kidney Disease Independent of Severity.
-
Postoperative Impact of Diabetes, Chronic Kidney Disease, Hemodialysis, and Renal Transplant After Total Hip Arthroplasty.
-
Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chronic kidney disease.
-
Prediction, progression, and outcomes of chronic kidney disease in older adults.
-
Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC).
-
Predictors of length of hospital stay in elderly hip fracture patients.
-
Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia.
-
Premature T Cell Senescence in Pediatric CKD.
-
Prevalence and Outcomes of Left-Sided Valvular Heart Disease Associated With Chronic Kidney Disease.
-
Prevalence and correlates of cardiometabolic multimorbidity among hypertensive individuals: a cross-sectional study in rural South Asia-Bangladesh, Pakistan and Sri Lanka.
-
Prevalence and health correlates of reduced kidney function among community-dwelling Chinese older adults: the China Health and Retirement Longitudinal Study.
-
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry.
-
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease.
-
Prevalence of apparent treatment-resistant hypertension among individuals with CKD.
-
Prevalence of chronic kidney disease in China.
-
Prevalence of reduced estimated glomerular filtration rate among the oldest old from 1988-1994 through 2005-2010.
-
Prevalence, Risk Factors, and Complications of Diabetes in the Kilimanjaro Region: A Population-Based Study from Tanzania.
-
Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study.
-
Primary Care Physicians' Perceived Barriers to Nephrology Referral and Co-management of Patients with CKD: a Qualitative Study.
-
Primary Medical Care Integrated with Healthy Eating and Healthy Moving is Essential to Reduce Chronic Kidney Disease Progression.
-
Primary care physicians' familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study.
-
Primary care physicians' perceptions of barriers and facilitators to management of chronic kidney disease: A mixed methods study.
-
Primary prevention of chronic kidney disease through population-based strategies for blood pressure control: The ARIC study.
-
Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes.
-
Prophylactic hydration to prevent contrast-induced nephropathy: much ado about nothing?
-
Proportion of US adults potentially affected by the 2014 hypertension guideline.
-
Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm?
-
Pruning the ricket thicket.
-
Psychosocial determinants of cardiovascular events among black Americans with chronic kidney disease or associated risk factors in the Jackson heart study.
-
Pulmonary Hypertension Is Associated With a Higher Risk of Heart Failure Hospitalization and Mortality in Patients With Chronic Kidney Disease: The Jackson Heart Study.
-
Pulmonary Hypertension Subtypes and Mortality in CKD.
-
Putting patients at the center of kidney care transitions: PREPARE NOW, a cluster randomized controlled trial.
-
Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program.
-
Race, Genetic Ancestry, and Estimating Kidney Function in CKD.
-
Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.
-
Racial Disparities in Invasive Management for Patients With Acute Myocardial Infarction With Chronic Kidney Disease.
-
Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease.
-
Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort.
-
Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial.
-
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.
-
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).
-
Rationale and design of the Kidney Precision Medicine Project.
-
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk.
-
Receipt and Sharing of Information to Improve Knowledge About Living Donor Kidney Transplant among Transplant Candidates with Advanced Chronic Kidney Disease.
-
Recognition of CKD after the introduction of automated reporting of estimated GFR in the Veterans Health Administration.
-
Recycling to discover something new: the role of autophagy in kidney disease.
-
Reducing CKD risks among vulnerable populations in primary care.
-
Regional variation in chronic kidney disease and associated factors in hypertensive individuals in rural South Asia: findings from control of blood pressure and risk attenuation-Bangladesh, Pakistan and Sri Lanka.
-
Regulation and Effects of FGF23 in Chronic Kidney Disease.
-
Relation of Baseline Renal Dysfunction With Outcomes in Patients Undergoing Popliteal and Infrapopliteal Percutaneous Peripheral Arterial Interventions.
-
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.
-
Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar.
-
Remote Usability Testing and Satisfaction with a Mobile Health Medication Inquiry System in CKD.
-
Renal Outcomes in Patients Bridged to Heart Transplant With a Left Ventricular Assist Device.
-
Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy.
-
Renal function and coronary bypass surgery in patients with ischemic heart failure.
-
Renal function outcomes after laparoscopic renal cryoablation.
-
Renal outcomes following left renal vein harvest for venous reconstruction during pancreas and liver surgery.
-
Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal function.
-
Research Priorities for Kidney-Related Research-An Agenda to Advance Kidney Care: A Position Statement From the National Kidney Foundation.
-
Reserve and resilience in CKD: concept introduction and baseline results from the Physical REsilience Prediction in Advanced REnal Disease (PREPARED) study.
-
Retinal Vascular Imaging Markers and Incident Chronic Kidney Disease: A Prospective Cohort Study.
-
Retinal arteriolar narrowing and subsequent development of CKD Stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA).
-
Retinal microvascular signs are associated with chronic kidney disease in persons with and without diabetes.
-
Retrospective cohort study of changes in estimated glomerular filtration rate for patients prescribed a low carb diet.
-
Revamping the 'renal' diet: using foods to control phosphorus physiology.
-
Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
-
Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents.
-
Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.
-
Risk factors for reduced glomerular filtration rate in a Nicaraguan community affected by Mesoamerican nephropathy.
-
Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism.
-
Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score.
-
Role of Acid-Base Homeostasis in Diabetic Kidney Disease.
-
Roles for SGLT2 Inhibitors in Cardiorenal Disease.
-
SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation.
-
Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.
-
Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database.
-
Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
-
Safety of Dual-Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease.
-
Screening for chronic kidney disease.
-
Self-Perceived Barriers and Facilitators to Dietary Approaches to Stop Hypertension Diet Adherence Among Black Americans With Chronic Kidney Disease: A Qualitative Study.
-
Self-reported Medication Adherence and Adverse Patient Safety Events in CKD.
-
Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.
-
Serum Calcification Propensity and Clinical Events in CKD.
-
Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.
-
Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes.
-
Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies.
-
Setting an agenda for comparative effectiveness systematic reviews in CKD care.
-
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment.
-
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
-
Socioeconomic status and microalbuminuria in an Asian population.
-
Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.
-
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
-
Specialist and primary care physicians' views on barriers to adequate preparation of patients for renal replacement therapy: a qualitative study.
-
Spirituality, Coping, and Resilience Among Rural Residents Living with Chronic Kidney Disease.
-
State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective.
-
Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
-
Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.
-
Statistical methods for building better biomarkers of chronic kidney disease.
-
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
-
Supermarket Proximity and Risk of Hypertension, Diabetes, and CKD: A Retrospective Cohort Study.
-
Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.
-
Survivorship and Complications after Hip Fracture Surgery in Patients with Chronic Kidney Disease.
-
Synergistic effect of chronic kidney disease and high circulatory norepinephrine level on stroke risk in Japanese hypertensive patients.
-
TRPC Channels in Proteinuric Kidney Diseases.
-
Targeting Fall Risk in CKD.
-
Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease.
-
Telehealth Applications to Enhance CKD Knowledge and Awareness Among Patients and Providers.
-
Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry.
-
The ASCEND-ND trial: study design and participant characteristics.
-
The Association of Kidney Function and Albuminuria With the Risk and Outcomes of Syncope: A Population-Based Cohort Study.
-
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction.
-
The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations.
-
The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease.
-
The Impact of Chronic Kidney Disease on Postoperative Outcomes in Patients Undergoing Lumbar Decompression and Fusion.
-
The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease.
-
The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
-
The Utility of Novel Renal Biomarkers in Assessment of Chronic Kidney Disease of Unknown Etiology (CKDu): A Review.
-
The association between smoking and long-term outcomes after non-ST-segment elevation myocardial infarction in older patients.
-
The balance of the evidence on acid-base homeostasis and progression of chronic kidney disease.
-
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
-
The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy.
-
The chronic kidney disease model: a general purpose model of disease progression and treatment.
-
The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis.
-
The growing burden of chronic kidney disease in Pakistan.
-
The impact of chronic kidney disease on outcomes following peripheral vascular intervention.
-
The interplay between CKD, sudden cardiac death, and ventricular arrhythmias.
-
The last mile: translational research to improve CKD outcomes.
-
The management of acute coronary syndromes in patients with chronic kidney disease.
-
The management of women with kidney disease.
-
The need for collaboration to improve cardiovascular outcomes in patients with CKD.
-
The pursuit of truth and beauty.
-
The transcription factor Twist1 in the distal nephron but not in macrophages propagates aristolochic acid nephropathy.
-
The varying roles of macrophages in kidney injury and repair.
-
Therapeutic options for chronic kidney disease-associated pulmonary hypertension.
-
Therapy insight: how changes in renal function with increasing age affect cardiovascular drug prescribing.
-
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial.
-
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD.
-
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
-
Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis.
-
Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.
-
Traditional medicine practices among community members with chronic kidney disease in northern Tanzania: an ethnomedical survey.
-
Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD.
-
Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010).
-
Trends in anemia management in US hemodialysis patients 2004-2010.
-
Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
-
Tubular Secretion in CKD.
-
Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension.
-
Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration.
-
Update on fibroblast growth factor 23 in chronic kidney disease.
-
Uric Acid and CKD Progression Matures with Lessons for CKD Risk Factor Discovery.
-
Urinary biomarkers indicate pediatric renal injury among rural farming communities in Sri Lanka.
-
Urinary cystatin C: pediatric reference intervals and comparative assessment as a biomarker of renal injury among children in the regions with high burden of CKDu in Sri Lanka.
-
Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
-
Urological complications and vesicoureteral reflux following pediatric kidney transplantation.
-
Usability Testing of a Sick-Day Protocol in CKD.
-
Usability of a CKD educational website targeted to patients and their family members.
-
Usability testing and acceptance of an electronic medication inquiry system for CKD patients.
-
Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.
-
Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease.
-
Use of a Medical-Alert Accessory in CKD: A Pilot Study.
-
Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry.
-
Using Zero Balance Ultrafiltration with Dialysate as a Replacement Fluid for Hyperkalemia during Cardiopulmonary Bypass.
-
Using social media to create a professional network between physician-trainees and the American Society of Nephrology.
-
Utility of implantable cardioverter defibrillators in chronic kidney disease.
-
Validation study of medicare claims to identify older US adults with CKD using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
-
Variation in Definitions of Kidney Abnormality in Patients with Spina Bifida: A Systematic Scoping Review.
-
Vascular calcification in chronic kidney disease: here to stay?
-
Vitamin D deficiency and anemia in early chronic kidney disease.
-
Warfarin for Atrial Fibrillation Stroke Prophylaxis in Advanced Kidney Disease: If You Are Not Confused, You Are Not Thinking Clearly.
-
We still go for the jugular: implications of the 3SITES central venous catheter study for nephrology.
-
Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4.
-
Keywords of People